U.S. Healthcare Services Stock News

Ecolab stock has delivered a 48.8% total return over the past three years, and at around US$272.83 per share the key question is whether that run now leaves it trading close to its intrinsic value or at a premium. The Discounted Cash Flow (DCF) estimate points to Ecolab being roughly fairly valued, while the broader valuation checks and market multiples lean more cautious. Ecolab's 48.8% return over three years means anyone who stayed invested has been rewarded, so fresh buyers now need to...

In July 2026, General Mills, ADM and Walmart announced a collaboration to expand regenerative agriculture across 40,000 Midwest wheat acres, offering farmers technical support and financial incentives to adopt practices such as no-till and cover crops. This three-way effort links ADM’s role as a major wheat supplier and manager of nearly 5 billion regenerative acres globally with large downstream buyers, creating a proof-of-concept for scaling sustainability across an integrated food supply...

RBC Capital recently downgraded ResMed to Sector Perform from Outperform, pointing to FY27 pressures from Astral ventilator replacements, higher input costs, and supply constraints on key components. The downgrade highlights how operational issues in a single product line can ripple through device sales, cost structure, and overall business planning for the coming years. Next, we’ll examine how expected FY27 cost pressures and supply bottlenecks may influence ResMed’s previously optimistic...

Coinbase Global (COIN) is back in focus after a series of leadership shifts, including changes at its Base platform and in senior legal roles, which coincide with heightened debate over US crypto regulation. See our latest analysis for Coinbase Global. Those leadership changes at Coinbase Global come after a period where momentum has cooled, with the share price down 23.85% over 90 days and year to date, and a 1 year total shareholder return down 62.57%, even though the 3 year total...

Ichor Holdings (ICHR) has drawn investor attention after recent share price moves, with the stock down 1.0% over the past day and 17.4% over the past week, following a period of strong multiyear total returns. See our latest analysis for Ichor Holdings. Zooming out, Ichor Holdings has seen its recent momentum fade, with the share price down 7.4% over the past month and 17.4% over the past week. However, the year to date share price return of 306.0% and 1 year total shareholder return of...

In Q1 2026, Duolingo used artificial intelligence to scale content production to over 20,500 course units and lifted daily active users 21% year on year to 56.5 million, reinforcing its AI-led approach to language learning. By linking its ambition to reach 100 million daily active users by 2028 with AI-enabled course creation, Duolingo has sharpened the tension between faster engagement growth and investor concerns about margin pressure as it heads into upcoming earnings. With Duolingo’s...

Recent commentary around eBay (EBAY) has focused on softer active buyer growth, a weaker sales outlook and rising expenses outpacing revenue, which is pressuring EBITDA margins and prompting investors to reassess the stock’s recent share price gains. See our latest analysis for eBay. At a latest share price of US$112.06, eBay’s 1 day share price return of 1.04% comes after a softer 7 day share price return of 4.39%. However, the year to date share price return of 28.72% and 1 year total...

Equinix, Inc. announced that Chief Business Officer Jon Lin left the company on July 18, 2026, with his responsibilities redistributed among existing senior leaders and plans underway to appoint a new Chief Product Officer to oversee product strategy and governance. This leadership reshuffle highlights Equinix’s emphasis on continuity and product focus as it manages executive turnover while maintaining its existing operating structure. Next, we’ll examine how this leadership transition,...

Why Invitation Homes Stock Is Drawing Attention Now Recent performance in Invitation Homes (INVH) stock, including a move of about 6% over the past month and roughly 11% over the past 3 months, has prompted closer investor attention. See our latest analysis for Invitation Homes. At a share price of $30.12, Invitation Homes has recorded a 5.72% 30 day share price return and an 11.43% 90 day share price return, yet its 1 year total shareholder return is down 2.44%, pointing to improving short...

Citigroup Inc. recently reported stronger second-quarter 2026 results, with higher net interest income, net income, and earnings per share, while also announcing a full US$1.50 billion redemption of its 6.250% Series T preferred stock in August 2026 as part of its funding and capital-structure optimization. At the same time, Citi expanded its fixed-income funding and advanced its digital payments and tokenization efforts, suggesting a tighter focus on capital efficiency, funding flexibility,...

Product update puts TransUnion’s mortgage data capabilities in focus TransUnion (TRU) has drawn fresh investor attention after adding TruVision Alternative Credit Attributes 2.0 from its FactorTrust Alternative Lending Database to its mortgage credit report. The update expands lender insight beyond traditional credit files. See our latest analysis for TransUnion. The TruVision update arrives after a strong 1 month share price return of 23.91% and a 7 day share price gain of 6.44%. However,...

Resideo Technologies has nearly doubled investors' money over the past three years, and the current valuation checks suggest the stock still trades at a discount, with the Discounted Cash Flow (DCF) intrinsic value estimate indicating room above the recent US$35.83 share price. Resideo Technologies has returned 98.4% over the past three years, which puts extra focus on whether that gain is fully backed by fundamentals. The planned spin off of the ADI Global Distribution business may support...

Voter support is tilting toward democratic socialist policies like universal healthcare, higher taxes on the wealthy, and more government-backed services, and that puts parts of the healthcare sector squarely under the spotlight. For investors, the bigger question is how potential future reforms and tougher oversight could affect margins, pricing power, and long term business models. This article examines the political catalysts behind this shift and then outlines 3 healthcare stocks that...

Advanced Micro Devices (AMD) has been in focus after Ark Investment Management highlighted the stock as one of its core artificial intelligence holdings, reflecting growing investor attention on AMD’s role in AI infrastructure. See our latest analysis for Advanced Micro Devices. The recent pullback, including a 1-day share price return of 1.03% and a 7-day share price return of 11.14%, comes after a strong run where AMD’s year-to-date share price return is 121.85% and its 1-year total...

Analyst Optimism Builds Ahead of Pool Corp Earnings Recent optimism around Pool (POOL) centers on its upcoming June-quarter earnings report, with expectations for higher revenue and a year over year EPS increase drawing fresh attention to the stock. See our latest analysis for Pool. Despite the upbeat earnings expectations, Pool's recent share price performance has been weak, with the stock closing at US$201.17 and the 1 year total shareholder return down 31.18%, which points to fading...

Fidelity National Information Services (FIS) has joined Project Glasswing, using Anthropic’s Mythos 5 frontier AI model to help identify security vulnerabilities in its infrastructure and support wider efforts around defensive cybersecurity in financial services. See our latest analysis for Fidelity National Information Services. These security and product updates come after a mixed period for Fidelity National Information Services. The share price is at US$41.91, with a 1 month share price...

Assurant stock has delivered a strong 124.2% return over the past three years, yet the valuation picture is split, with the Excess Returns intrinsic value estimate pointing to meaningful upside while market multiples suggest the shares trade at a premium. Over three years, Assurant has returned 124.2%, which puts extra focus on whether today’s price still leaves room for attractive risk adjusted returns. Upcoming earnings, where analysts expect pressure on EPS, may influence views on the...

Uniti Group (UNIT) drew fresh investor attention after its indirect subsidiary Kinetic ABS Issuer completed a private offering of $1.14b in secured fiber network revenue term notes tied to its fiber to the home securitization program. See our latest analysis for Uniti Group. At a share price of $11.04, Uniti Group has seen a 1-day share price return of 0.55% and a year to date share price return of 61.64%. The 1-year total shareholder return of 38.96% contrasts with weaker 5-year total...

Stryker stock has given investors a 28.3% total return over the past five years, yet its current share price around US$319 sits at a point where the Discounted Cash Flow (DCF) estimate suggests room for upside, while the broader checks paint a more cautious picture. A 28.3% return over five years indicates that Stryker has rewarded patient shareholders without delivering an outsized run that would obviously stretch valuation. The launch of the Mako RPS handheld robotic system can support...

Electronic Arts (EA) has put its Battlefield franchise front and center with a first look at Battlefield 6 and Battlefield REDSEC, using their largest seasonal update yet and a Top Gun crossover to refocus attention on the stock. See our latest analysis for Electronic Arts. The recent Battlefield announcements come on top of a steady run of product news around College Football 27, NHL 27 and in game advertising. Together these sit against a 1 year total shareholder return of 39.7% and a 3...

Earlier in July 2026, U.S. regulators expanded approval of Vertex’s gene-editing therapy Casgevy to children as young as 2 with sickle cell disease or transfusion-dependent thalassemia, while Canada’s pan-Canadian Pharmaceutical Alliance signed a Letter of Intent with Vertex to enable public reimbursement discussions for its cystic fibrosis therapy ALYFTREK. These moves deepen Vertex’s reach in severe genetic diseases by both widening the eligible patient pool for Casgevy and advancing payer...

S&P Global stock has delivered a 5 year return of 18.8%, yet its valuation checks currently lean expensive, which raises the question of how much of the story around new products and operating changes is already reflected in the US$450.84 share price. That 18.8% return over five years suggests S&P Global has rewarded patient shareholders, but not at a pace that clearly justifies paying any price for future growth. New offerings such as ETF Intelligence and a refreshed Market Intelligence...

Ameris Bancorp (ABCB) heads into its next earnings report on July 23 with expectations for higher year over year earnings and revenue, putting fresh attention on how the stock prices in those forecasts. See our latest analysis for Ameris Bancorp. The recent 7 day share price return of 2.10% and 30 day share price return of 7.32% suggest momentum has been building in Ameris Bancorp ahead of its earnings update. At the same time, the 1 year total shareholder return of 38.48% and 3 year total...

In the past week, Travelers Companies reported second-quarter 2026 results, with revenue of US$12.15 billion and net income of US$2.21 billion, alongside sharply higher basic and diluted earnings per share from continuing operations versus a year earlier. At the same time, Travelers declared a regular US$1.25 quarterly dividend, continued buybacks, and filed a US$2.70 billion shelf registration for an ESOP-related common stock offering, highlighting an active approach to capital returns and...